LAKE MARY, Fla. (Jan. 22)—BarrierPlus surgical gloves made by BarrierMed Inc. are undergoing review by the U.S. Food and Drug Administration with a decision on the synthetic product´s commercial use expected by April, when the firm plans a global launch of the gloves. BarrierMed, which currently manufactures neoprene examination gloves for hospitals and medical centers, also is negotiating a three-year agreement with American Health Products, a worldwide distributor of health care products, to market the surgical gloves. BarrierPlus gloves use a new cut resistant polymer technology patented by the company earlier this year, according to Victor Ragucci, BarrierMed founder and president.
BarrierMed gloves get FDA review
Rubber News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].